SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

bioAffinity Technologies to Present Asthma and COPD Research Data at CHEST 2026

bioAffinity Technologies said it will present data on a test measuring lung inflammation and drug-related receptors at CHEST 2026.

BIAF